Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
, 13 (11), 936-45

Differences in Outcome According to Clostridium Difficile Testing Method: A Prospective Multicentre Diagnostic Validation Study of C Difficile Infection

Comparative Study

Differences in Outcome According to Clostridium Difficile Testing Method: A Prospective Multicentre Diagnostic Validation Study of C Difficile Infection

Timothy D Planche et al. Lancet Infect Dis.


Background: Diagnosis of Clostridium difficile infection is controversial because of many laboratory methods, compounded by two reference methods. Cytotoxigenic culture detects toxigenic C difficile and gives a positive result more frequently (eg, because of colonisation, which means that individuals can have the bacterium but no free toxin) than does the cytotoxin assay, which detects preformed toxin in faeces. We aimed to validate the reference methods according to clinical outcomes and to derive an optimum laboratory diagnostic algorithm for C difficile infection.

Methods: In this prospective, multicentre study, we did cytotoxigenic culture and cytotoxin assays on 12,420 faecal samples in four UK laboratories. We also performed tests that represent the three main targets for C difficile detection: bacterium (glutamate dehydrogenase), toxins, or toxin genes. We used routine blood test results, length of hospital stay, and 30-day mortality to clinically validate the reference methods. Data were categorised by reference method result: group 1, cytotoxin assay positive; group 2, cytotoxigenic culture positive and cytotoxin assay negative; and group 3, both reference methods negative.

Findings: Clinical and reference assay data were available for 6522 inpatient episodes. On univariate analysis, mortality was significantly higher in group 1 than in group 2 (72/435 [16·6%] vs 20/207 [9·7%], p=0·044) and in group 3 (503/5880 [8·6%], p<0·001), but not in group 2 compared with group 3 (p=0·4). A multivariate analysis accounting for potential confounders confirmed the mortality differences between groups 1 and 3 (OR 1·61, 95% CI 1·12-2·31). Multistage algorithms performed better than did standalone assays.

Interpretation: We noted no increase in mortality when toxigenic C difficile alone was present. Toxin (cytotoxin assay) positivity correlated with clinical outcome, and so this reference method best defines true cases of C difficile infection. A new diagnostic category of potential C difficile excretor (cytotoxigenic culture positive but cytotoxin assay negative) could be used to characterise patients with diarrhoea that is probably not due to C difficile infection, but who can cause cross-infection.


Figure 1
Figure 1
Patient and sample selection CC=cytotoxigenic culture. CTA=cytotoxin assay.
Figure 2
Figure 2
AUROCs (median and 95% CI) for each individual assay and algorithms (A) Comparison with the cell cytotoxicity reference method. (B) Comparison with the cytotoxigenic culture reference method. Comparisons were done in the training phase. Error bars represent 95% CIs. AUROC= area under the receiver operator characteristic curve. GDH=glutamate dehydrogenase.

Comment in

Similar articles

See all similar articles

Cited by 122 PubMed Central articles

See all "Cited by" articles


    1. Klevens RM, Edwards JR, Richards CL., Jr Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–166. - PMC - PubMed
    1. Dallal RM, Harbrecht BG, Boujoukas AJ. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235:363–372. - PMC - PubMed
    1. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173:1037–1042. - PMC - PubMed
    1. Wilson V, Cheek L, Satta G. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis. 2010;50:e77–e81. - PubMed
    1. Pepin J, Valiquette L, Alary ME. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466–472. - PMC - PubMed

MeSH terms